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Light-inducible receptor tyrosine kinases that
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Receptor tyrosine kinases (RTKs) are a family of cell-surface receptors that have a key role in
regulating critical cellular processes. Here, to understand and precisely control RTK signalling,
we report the development of a genetically encoded, photoactivatable Trk (tropomyosin-
related kinase) family of RTKs using a light-responsive module based on Arabidopsis thaliana
cryptochrome 2. Blue-light stimulation (488 nm) of mammalian cells harbouring these
receptors robustly upregulates canonical Trk signalling. A single light stimulus triggers
transient signalling activation, which is reversibly tuned by repetitive delivery of blue-light
pulses. In addition, the light-provoked process is induced in a spatially restricted and
cell-speciﬁc manner. A prolonged patterned illumination causes sustained activation of
extracellular signal-regulated kinase and promotes neurite outgrowth in a neuronal cell line,
and induces ﬁlopodia formation in rat hippocampal neurons. These light-controllable
receptors are expected to create experimental opportunities to spatiotemporally manipulate
many biological processes both in vitro and in vivo.
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C
ells respond to their environment by transducing external
stimuli, for example growth factors and hormones, into
relevant internal signals via cell-surface receptors, such as
G-protein-coupled receptors1 and receptor tyrosine kinases
(RTKs)2. By binding to their ligands, receptors mediate the
activation of diverse intracellular signalling pathways and regulate
numerous cellular processes. Accordingly, natural ligands or
synthetic agonists have been broadly used as indispensable tools
to speciﬁcally control receptor activity and probe the mechanisms
underlying cellular behaviours. However, they do not allow
spatial control and have temporal resolution that is limited by
time required for diffusion, making it difﬁcult or impossible to
dissect and analyse the dynamic nature of cellular signalling
networks in a spatiotemporally precise manner. One promising
approach to circumvent these limitations is coupling light signals
to receptor activity. Because the activating stimulus (light) can be
delivered with high spatiotemporal speciﬁcity, and even simply
switched on and off, experimental opportunities are created
that would not be possible with classical ligand-based and
pharmacological methods. To date, efforts to control cell
signalling through optical modulation of receptor activity have
mainly used vertebrate rhodopsin, as exempliﬁed by engineered
chimeric receptors that combine rhodopsin with G-protein-
coupled receptors3,4.
Recently developed light-responsive interacting modules5–7
may represent a new strategy for light activation of receptors.
The members of a module pair, which are based on plant
photoreceptors derived from Arabidopsis thaliana, are genetically
encoded and allow control of protein–protein interactions in
mammalian cells in a light-dependent fashion, thereby suitable
for application to receptor systems that are activated by an
interaction between receptor monomers, such as RTKs.
Normally, RTK activation is induced by ligand-mediated
receptor dimerization (Fig. 1a), which in turn leads to auto-
phosphorylation of tyrosine kinase domains and recruitment of
downstream signalling molecules2. However, this interaction, and
thus receptor activation, can be induced artiﬁcially using chemical
inducers of dimerization (CIDs)8. In this application, tyrosine
kinase domains are fused to the binding domain(s) recognized by
CIDs, allowing RTKs to be pharmacologically crosslinked and
activated, independently of their endogenous counterpart
and ligand, in the presence of CIDs such as rapamycin or
AP20187 (refs 9–11). Accordingly, we reasoned that the light-
mediated interactions could functionally substitute for the CID
approach and allow RTKs to be dimerized and activated in
response to light.
In this study, our goal was to develop photoactivatable RTKs.
The tropomyosin-related kinase (Trk) family was chosen as a
candidate light-induced RTK. Following binding to neuro-
trophins, the three members of this family, Trk A, B and C,
mediate activation of intracellular signalling pathways, including
mitogen-activated protein kinase kinase (MEK)/extracellular
signal-regulated kinase (ERK), phosphatidylinositol 3-kinase
(PI3K)/Akt and phospholipase Cg1 (PLCg1)/Ca2þ pathways,
and thereby contribute to neuronal survival, neurite outgrowth
and synaptic plasticity12. As a light-inducible dimerization
system, we initially introduced the photolyase homology region
(PHR) of cryptochrome 2, a blue-light photoreceptor, and its
optically driven interaction partner CIBN, an N-terminal domain
of CIB1, because the PHR-CIBN pair achieves fast and precise
control of protein–protein interactions upon blue-light exposure
with no requirements for exogenous cofactors7. However, we
unexpectedly found that PHR can be harnessed as a homo-
interaction domain to activate the linked Trk receptors in
response to light (Fig. 1 and Supplementary Fig. 1). Exploiting
this serendipitous outcome, we were able to achieve optically
activatable Trk signalling using a single light-responsive module
(Fig. 1b).
Here we show that light stimulation can activate canonical Trk
signalling pathways through photoactivatable Trk receptors,
designated optoTrks. Using one of the receptors, optoTrkB,
we representatively show that TrkB signalling is rapidly and
transiently controlled by a single photostimulation in a reversible,
spatial and cell-speciﬁc manner. In addition, a prolonged
patterned stimulation (illumination) of a neuronal cell line
harbouring optoTrkB sustains ERK activity and induces neuronal
differentiation. Finally, we further demonstrate the utility of
optoTrk receptors by showing that blue-light exposure can trigger
PI3K signalling activation and regulate neurite outgrowth, as well
as ﬁlopodia formation in rat hippocampal neurons.
Results
Design of optoTrk receptors. As schematically illustrated in
Supplementary Fig. 1a, we originally designed two different
chimeric receptors containing full-length Trk, one consisting of
Trk linked to PHR and the monomeric yellow ﬂuorescent protein
mCitrine (Trk-PHR-mCit), and the other consisting of Trk linked
to CIBN and the monomeric cyan ﬂuorescent protein mCerulean
(Trk-CIBN-mCer). To test the PHR-CIBN interaction-mediated
activation of Trk signalling in mammalian cells, we ﬁrst con-
structed PHR- and CIBN-fused TrkB receptors and expressed
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Figure 1 | Design and functional expression of photoactivatable Trk receptors. Schematic illustration of the molecular architecture and activation
process of (a) Trk and (b) optoTrk receptors. Sites of induced monomer interaction are denoted by left right arrows. ED, extracellular domain; TKD,
tyrosine kinase domain; and mCit, mCitrine. (c) Fluorescence images of optoTrk receptors and ERK-mCherry co-expressed in HeLa cells. ERK-mCherry
(ERK-mCh) was imaged before and 5min after a single-light stimulation (488 nm, three 0.5-s pulses, 6.5 mW). Graphs on the right show the normalized
ratio of nucleus and cytosol ERK-mCh ﬂuorescence (ERKnuc/ERKcyt) before (grey bar) and after (blue bar) blue-light exposure. Scale bars, 20mm.
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them together or individually in PC12 or HeLa cells, both
of which do not express endogenous TrkB receptors13,14.
Illumination of cotransfected PC12 cells using a blue LED array
(470nm, 5.5mW) caused an increase in endogenous phospho-ERK
level (Supplementary Fig. 1b), suggesting a light-induced activation
of ERK signalling. Unexpectedly, we found that TrkB-PHR-mCit
alone was able to activate ERK in response to light stimulation,
whereas TrkB-CIBN-mCer was not (Supplementary Fig. 1b). To
further verify this phenomenon, we imaged intracellular Ca2þ
level ([Ca2þ ]i). Exposure of HeLa cells harbouring both of the two
chimeric receptors to blue-light stimulation (488nm, three 0.5 s
pulses, 6.5mW) evoked a Ca2þ transient, as demonstrated by an
increase in the ﬂuorescence intensity of cotransfected,
intensiometric Ca2þ indicator (R-GECO1)15 shown in
Supplementary Fig. 1c. Again, TrkB-PHR-mCit alone was
sufﬁcient to drive changes in [Ca2þ ]i in response to blue-light
pulses, whereas TrkB-CIBN-mCit, mCitrine-tagged TrkB (TrkB-
mCit), or mCitrine-tagged PHR (PHR-mCit) did not elevate
[Ca2þ ]i after light stimulation (Supplementary Fig. 1c). Moreover,
we did not observe light-triggered Ca2þ signal when TrkB
receptor linked to a light-insensitive PHR mutant (PHRD387A)16
(TrkB-PHRD387A-mCit) was expressed (Supplementary Fig. 1c).
Collectively, these results suggested that the PHR domain alone is
able to confer a light-inducible interaction capacity on the linked
TrkB receptor, thereby allowing it to mediate ERK and Ca2þ
signalling in response to light. Thus, using a single light-dependent
homo-interaction domain, we were able to construct a
photoactivatable TrkB receptor, designated optoTrkB (Fig. 1b).
Extending this concept to other members of the Trk family, we also
constructed photoactivatable TrkA and TrkC receptors, optoTrkA
and C (Fig. 1b).
Light-induced upregulation of canonical Trk signalling. To
validate functional expression of optoTrks, we used biosensors
of intracellular ERK, AKT and Ca2þ signalling activity to assay
light-induced activation of canonical Trk signalling cascades in
individual HeLa cells by live-cell imaging. Blue-light illumination
of cells transfected with each optoTrk receptor clearly caused
nuclear translocation of monomeric (m)Cherry-tagged ERK
(ERK-mCh), indicating ERK pathway activation17 (Fig. 1c). In
addition, light stimulation promoted plasma membrane
localization of the pleckstrin homology domain of mCherry-
tagged AKT1 (mCh-PHAKT1) (Supplementary Fig. 2a), indicating
PI3K/Akt signalling activation18, and resulted in an increase
in R-GECO1 signal, demonstrating [Ca2þ ]i elevation
(Supplementary Fig. 2b). Taken together, these results indicate
that optoTrk receptors can induce upregulation of ERK, AKT and
Ca2þ signalling pathways upon blue-light exposure. Among the
modiﬁed receptors, we used optoTrkB for all follow-up studies.
Differential regulation of TrkB signalling by BDNF and light.
TrkB signalling is activated by binding of TrkB receptor to its
cognate ligand brain-derived neurotrophic factor (BDNF)19, and
the BDNF-binding sites within optoTrkB remain intact. Thus, to
characterize the light-triggered activation of TrkB signalling
cascades in more detail, we co-expressed optoTrkB with ERK-,
PI3K- and Ca2þ -biosensors, and monitored and analysed their
responses to BDNF or blue-light stimulation in a time-dependent
manner. At ﬁrst, both stimuli caused an increase of ERK-mCh in
the cell nucleus (Fig. 2a) and an accumulation of mCh-PHAKT1
at the plasma membrane (Fig. 2b). Kinetic measurements of
ERK-mCh and mCh-PHAKT1 translocation, however, revealed
a common, stimulus-dependent difference: BDNF (50 ngml 1)
induced relatively slow, sustained signalling activation in
optoTrkB-expressing cells during the examined periods
(Fig. 2a–c), whereas blue light triggered rapid, transient
responses (Fig. 2a–c). For example, the normalized nucleus/
cytosol ratio of ERK-mCh was gradually increased and
maintained at the elevated level, at least until 20min, in the
presence of BDNF, but it was rapidly increased and declined to
the baseline after a single light stimulation (Fig. 2c). Changes in
ERK phosphorylation states, revealed by an immunoblot analysis,
after applying the two stimuli were also consistent with this
observation (Supplementary Fig. 3).
Ca2þ signalling kinetics showed a similar difference between
the two stimuli. [Ca2þ ]i elevation by BDNF (100 ngml 1) was
induced slowly and sustained above the basal level for 42min,
whereas light-provoked Ca2þ transients was rapidly developed
and disappeared within 90 s (Fig. 2d,e). The slow kinetics of TrkB
signalling induced by activation with BDNF was attributable, in
part, to the time required for BDNF diffusion and the
concentration used. For example, doubling the amount of BDNF
from 50 to 100 ngml 1 shortened the time to the onset of a
Ca2þ surge (deﬁned as a 50% increase in [Ca2þ ]i above baseline)
from 67.9±7.6 to as little as 27±3.3 s (mean±s.e.m.; Fig. 2e).
Light stimulation caused a much faster Ca2þ surge (within
17.6±3.1 s (mean±s.e.m.); Fig. 2e), demonstrating the much
greater temporal resolution of optically activated TrkB signalling.
In contrast to responses to BDNF, which were somewhat
sustained, responses to light stimulation of optoTrkB were short-
lived and rapidly recovered to baseline. This was true for ERK and
AKT activity (Fig. 2a–c), as well as changes in [Ca2þ ]i (Fig. 2d,e).
In addition, when we compared the optoTrkB performance by
light with wild-type TrkB receptor activity by BDNF, similar
differences in signalling activation kinetics were observed
(Supplementary Fig. 4a–d). Taken together, these observations
suggest that optoTrkB enables transient activation of the
canonical TrkB signalling by a single photostimulation.
Signalling speciﬁcity of optoTrkB. We investigated the
signalling speciﬁcity of optoTrkB. Light-induced ERK activation
was totally eliminated by PD0325901, a MEK inhibitor
(Supplementary Fig. 5a). In addition, LY294002, a PI3K inhibitor,
and U73122, a PLC inhibitor, completely blocked light-mediated
translocation of mCherry-PHAKT1 to the plasma membrane
(Supplementary Fig. 5b) and light-triggered [Ca2þ ]i elevation
(Fig. 2d,e), respectively. Notably, those light-driven responses
were abolished by K252a, a selective inhibitor of Trk tyrosine
kinase activity (Supplementary Fig. 5 and Fig. 2d,e). These results
indicate that the stimulatory effect of blue light on cells expressing
optoTrkB is mediated through speciﬁc signalling cascades
emanating from TrkB activation.
Versatile control of TrkB signalling using optoTrkB. We
postulated that it would be feasible to achieve versatile control of
light-gated TrkB signalling by manipulating illumination meth-
ods. To explore this, we took advantage of the fast response and
recovery time (o90 s from activation to recovery; Fig. 2e) and
simple readout of Ca2þ imaging. Exposure of HeLa cells
cotransfected with optoTrkB and R-GECO1 to initial three 0.5-s
blue-light pulses induced a rapid increase and subsequent decline
in R-GECO1 ﬂuorescence. After a 10-min interstimulus interval
(ISI), a second photostimulation caused a change in intensity
similar to that of the ﬁrst stimulation (Fig. 3a,b and
Supplementary Movie 1), demonstrating that this process can be
controlled in a reversible manner. We further investigated the
reversibility efﬁcacy (deﬁned as the ratio of the second peak
amplitude to the ﬁrst peak amplitude) of light-switched activation
of TrkB-PLCg1-Ca2þ signalling by varying ISIs. At ISIs of or
longer than 5min (5 and 10min), a second Ca2þ transient was
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evoked with little or no loss of efﬁcacy, whereas at ISIs shorter
than 5min (4 and 3min), a second stimulus elicited a reduced
response in a stepwise fashion (Fig. 3c and Supplementary Fig. 6).
And, delivery of two light stimuli spaced 2min apart did not
induce a second Ca2þ signal (Fig. 3c and Supplementary Fig. 6),
overall suggesting a linear relationship between ISI and
reversibility efﬁcacy. Based on these results, we could repeatedly
generate robust [Ca2þ ]i elevations (at least ﬁve times) in a single
cell with a train of blue-light pulses at a constant ISI (10min)
(Fig. 3d).
We next examined the subcellular resolution and spatial
selectivity of optically activated TrkB signalling. Whole-cell
illumination, in which light stimulation is conﬁned to the whole
area of a single cell, caused an increase in [Ca2þ ]i simultaneously
throughout the cell (Fig. 3e, top). In contrast, when blue-light
pulses were delivered locally, Ca2þ signals were generated
precisely from at each edge of a single cell and then propagated
(Fig. 3e, middle and bottom). Thus, we were able to achieve ﬁne
spatial control of TrkB signalling. Moreover, in a mixed cell
population containing HeLa cells with and without optoTrkB
expression, global photostimulation, in which an illumination
area covers more than one cell, selectively increased [Ca2þ ]i only
in cells expressing optoTrkB (Fig. 3f and Supplementary Movie
2), demonstrating cell-speciﬁc modulation of signalling.
In addition to Ca2þ signal, an investigation of endogenous
ERK activity demonstrated that TrkB signalling activity was
light-controllable. Upon exposure of a population of optoTrkB-
transfected HeLa cells to a 1-min global illumination (470 nm)
using a blue LED array, phospho-ERK level was increased
approximately ﬁvefold after 5min and declined after 25min
(Supplementary Fig. 7). A subsequent, second stimulation applied
after a 25-min interval gave rise to a second increase in phospho-
ERK (Supplementary Fig. 7), conﬁrming that endogenous
signalling activity in a group of optoTrkB-expressing cells can
be reversibly and synchronously modulated by light.
Light-induced neurite outgrowth by sustaining ERK activity.
One of the prominent trophic effects of neurotrophins in Trk-
expressing neuronal cells is promotion of neurite outgrowth.
Nerve growth factor-induced neurite outgrowth in the rat
pheochromocytoma cell line, PC12, has been extensively studied
and characterized in this context20,21. Nerve growth factor
treatment of PC12 cells, which endogenously express TrkA,
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Figure 2 | BDNF and light stimulation differentially affected on TrkB signalling kinetics. Time-lapse images showing (a) nuclear translocation of
ERK-mCh and (b) plasma membrane recruitment of mCh-PHAKT1 in response to stimulation of optoTrkB-cotransfected HeLa cells with BDNF (50ngml
 1)
or blue light (three 0.5-s pulses, 6.5mW). OptoTrkB expression is shown on the left. Scale bars, 20mm. (c) Translocation kinetics of ERK-mCh and
mCh-PHAKT1 after stimulation (arrow) of optoTrkB-cotransfected HeLa cells with BDNF or blue light. The graph shows quantiﬁed translocation by
calculating the ratio of nuclear to cytosolic ERK-mCh (ERKnuc/ERKcyt) and changes in cytosolic mCh-PHAKT1, each normalized to baseline (at  1min;
dotted lines). Coloured numbers on each axis of the graph display different timescales and fold-change scales between ERK-mCh (red) and mCh-PHAKT1
(blue) translocation. Error bars, ±s.e.m. (n48). (d) Time course of changes in R-GECO1 ﬂuorescence in HeLa cells expressing the indicated
constructs before and after exposure to BDNF (100 ngml 1) or light. Cells were photostimulated with or without a 30-min pre-incubation with
100nM K252a or 2.5mM U73122. Scale bars, 20mm. (e) Ca2þ signalling kinetics in HeLa transfected and stimulated as in d. Intracellular Ca2þ levels
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induces neuronal differentiation, a process in which sustained
activation of ERK is essential20,21. Because TrkA and TrkB
signalling pathways involve similar signalling proteins and
PC12 cells expressing TrkB respond to BDNF by extending their
neurites22, we exploited this morphological response as a
functional readout to evaluate whether light stimulation could
mimic the biological effects of BDNF/TrkB signalling in optoTrkB-
transfected PC12 cells. We ﬁrst optimized illumination conditions
by varying illumination duration and ISIs based on the light-
triggered ERK dynamics in HeLa (Supplementary Figs 3 and 4)
at a constant laser power (5.5mW). Exposure of PC12 cells
transfected with optoTrkB to a single 5-s illumination with blue
LED (470nm) led to a rapid increase in the level of active ERK
within 5min, which diminished thereafter (Fig. 4a); these results
paralleled those obtained in HeLa cells (Supplementary Figs 3 and
4). Notably, exposure to repetitive illumination (5 s on/5min off)
induced a high level of active ERK that was sustained for at least
4 h (Fig. 4a). Thus, we could produce long-duration ERK activity
by stimulating optoTrkB-mediated signalling using a repetitive,
alternating light-ON/light-OFF protocol.
Adopting this illumination protocol, we stimulated optoTrkB-
transfected PC12 cells with blue-light pulses for 24 h and
examined neurite outgrowth after phalloidin staining. In the
absence of a stimulus, the morphology of undifferentiated PC12
cells was not affected by the expression of optoTrkB (Fig. 4b,c).
In addition, repetitive illumination did not promote neurite
formation in non-transfected PC12 cells (Fig. 4b, white arrow-
heads; and Fig. 4c, mock). However, 24-h repetitive irradiation
markedly induced neurite extensions in optoTrkB-transfected
PC12 cells, producing an effect comparable to that of BDNF
stimulation (Fig. 4b,c). The neurite outgrowth responses were
affected by light intensity; the total neurite length and the length
of the longest neurite was increased in an illumination dose-
dependent manner (Supplementary Fig. 8). In addition, we also
monitored light-driven neurite outgrowth by using real-time,
live-cell imaging (Supplementary Movie 3). In line with the
staining data, repetitive light stimulation caused morphological
changes in optoTrkB-expressing PC12 cells that did not occur in
the absence of illumination. Taken together, these results indicate
that BDNF/TrkB signalling activity was recapitulated by light
control of optoTrkB. More importantly, they also suggest that
optoTrkB expression, which, in theory, could lead to receptor
auto-activation23, did not spontaneously cause any marked
biological consequences; expression of these receptors was
functionally effective only when coupled with light stimulation.
Functional expression of optoTrkB in primary neurons.
Finally, we examined optoTrkB performance in cultured rat
hippocampal neurons. In a neuron at 7 DIV, which was
cotransfected with optoTrkB and mCh-PHAKT1, blue-light
irradiation triggered rapid translocation of mCh-PHAKT1 to the
plasma membrane in the soma (Supplementary Fig. 9a–c),
thereby demonstrating optoTrkB functionality. During this
observation, we also found that ﬁlopodia- and lamellipodia-like
structures (yellow arrows and blue arrowheads, respectively) were
formed in the perisomatic region of the irradiated neuron
(Supplementary Fig. 9d). Given that BDNF/TrkB signalling
c
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activity has shown to drive an activity-dependent synapse
formation process24, in part by inducing ﬁlopodia and spine
formation, and based on our observation, we next investigated
light-induced ﬁlopodia formation using optoTrkB. For the
visualization of the ﬁlopodial dynamics, we co-expressed
mCherry-tagged LifeAct (mCh-LifeAct), which stains
ﬁlamentous actin25. At ﬁrst, live-cell imaging of hippocampal
neurons overexpressing wild-type TrkB (TrkB-mCit) showed that
BDNF (100 ngml 1) treatment induced the ﬁlopodia formation
(Supplementary Fig. 10a–c). The number of ﬁlopodia in
neuritic processes was increased by nearly twofold after a
10-min administration of BDNF and plateaued thereafter
(Supplementary Fig. 10c). Based on this, we next examined
optoTrkB- and TrkB-mCit-transfected neurons after light and
BDNF stimulation, respectively, for 30min. OptoTrkB expression
per se did not augment neuronal ﬁlopodia density in the dark,
comparable to that caused by TrkB-mCit expression in the
absence of BDNF (Supplementary Fig. 11a–c). However,
repetitive or continuous illumination induced a signiﬁcant
increase in the number of ﬁlopodia (Supplementary Fig. 11c).
In addition, focal photostimulation elicited a spatially restricted
formation of ﬁlopodia (Fig. 5a–c). Time-lapse imaging of a single
neuron expressing optoTrkB and mCh-LifeAct revealed that
when exposed to a localized irradiation, the number of ﬁlopodia
was increased only within the stimulated area but not in nearby
non-stimulated area (Fig. 5b,c). Taken together, these results
demonstrated an optical control of ﬁlopodial formation using
optoTrkB in a temporally precise and spatially speciﬁc fashion.
We also tested the effects of pulsatile optoTrkB activation on
the neurite outgrowth process in young hippocampal neurons. To
this end, we expressed optoTrkB in freshly dissociated hippo-
campal neurons and stimulated them with BDNF (100 ngml 1)
or light (25 mW) from DIV 1 to DIV 3 (for 48 h), during which
neuronal polarity is spontaneously established26 (control;
Supplementary Fig. 12a). Blue-light illumination, as well as
BDNF incubation, signiﬁcantly increased the total neurite length
(Supplementary Fig. 12b) and the number of branch points
(Supplementary Fig. 12c) in young hippocampal neurons. BDNF
incubation caused more prominent effects on neurite outgrowth
than light stimulation, likely through the binding of BDNF to
endogenous TrkB or p75 neurotrophic receptors19.
In addition to validating its functionality in primary neurons,
we also monitored vesicular transport of optoTrkB receptor.
Upon ligand binding at the axonal terminal, TrkB receptor is
internalized and delivered in the retrograde direction, and thereby
initiates retrograde signalling27. Therefore, BDNF signalling in
neurons relies on proper transport of its TrkB receptor28. We
compared the axonal transport of TrkB-mCit and optoTrkB in
hippocampal neurons (Fig. 6a,b). A few vesicles were immobile
(white asterisks) but most of them were mobile (arrows). And
similarly as TrkB-mCit (Fig. 6a), optoTrkB receptors were
actively retrogradely transported along the axon (Fig. 6b),
demonstrating that the modiﬁed TrkB receptor was able to be
internalized and transported in hippocampal neurons.
Discussion
Light control of cell signalling offers an unprecedented opportunity
to interrogate the spatial and temporal dynamics of intracellular
signalling circuits29. Moreover, it also opens new avenues for
investigating causal links between biochemical signalling and
animal behaviour3. By simply combining a light-sensitive homo-
interaction module with a receptor-dimerization system—and
without considerable engineering—we have added new single-
component optogenetic tools, optoTrk receptors (Fig. 1b,c and
Supplementary Fig. 2), to the existing light-controllable toolkit.
OptoTrk receptors provoke upregulation of canonical Trk
pathways in response to blue-light exposure (Fig. 1c and
Supplementary Fig. 2), demonstrating that receptor modiﬁcation,
the addition of PHR domain and mCitrine (Fig. 1b) does not
alter signalling activity of native receptors. In addition, a
photoactivatable form of TrkB mutated at Tyr-816 (Y816F)30
(TrkBY816F-PHR-mCit), which is the PLCg1-binding site, failed to
elevate [Ca2þ ]i after blue-light stimulation (Supplementary
Fig. 13), further supporting that speciﬁc tyrosine phosphorylation,
but not the C-terminally fused domains, inﬂuences the binding of
proteins that are recruited at TrkB receptor.
The Trk receptors, like most RTKs, are activated by ligand-
induced receptor dimerization. Accordingly, overexpression of
them are prone to receptor auto-activation in the absence of
stimulus23. Indeed, for example, a modest induction of optoTrkB
activation in the dark state, as demonstrated by an increase in
ERK phosphorylation without illumination, was evident in HeLa
cells (Supplementary Figs 3a and 5a), which may limit the utility
of optoTrkB. However, we also observed that ﬁrst, TrkB-mCit
expression in HeLa cells was also shown to induce ERK
phosphorylation in the absence of BDNF treatment
(Supplementary Fig. 4c); and second, no signiﬁcant increase in
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background ERK activity was observed in PC12 cells regardless of
optoTrkB expression level (Supplementary Fig. 14). Thus, these
results suggest that not optoTrkB expression per se, but cell lines
for its expression was responsible for the background signal
activity.
A light-inducible protein–protein interaction with fast associa-
tion and dissociation kinetics has the beneﬁts of temporally
precise control of cell signalling. Moreover, a genetically encoded
dimerization system based on light-mediated protein homo-
interactions is highly favourable compared with that based on
protein hetero-interactions. The photoactivatable receptors in this
study, optoTrks, are based on PHR domain of cryptochrome 2 as
a single light-responsive dimerizer. And upon blue-light expo-
sure, optoTrk(B) rapidly (within seconds) and transiently (for a
few minutes) activates corresponding signalling pathways (Fig. 2)
without the need for exogenous cofactors, thus PHR meets the
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requirements for an ideal optogenetic dimerizer. The light-
dependent homo-interaction property of PHR described here has
been recently reported, showing that PHR can be oligomerized
and form clusters by blue-light illumination in mammalian
cells31. Thus, as suggested31, our results further support that PHR
can be harnessed as a single light-sensitive module to induce
protein–protein interaction and can be adapted to a broad range
of signalling molecules, including other RTK families.
Our light-dependent strategy offers several advantages over
conventional ligand-based or pharmacological approaches,
including those use organic compounds (such as CIDs) and
engineered receptors9–11, for the control of receptor signalling.
First, it has high temporal resolution, producing faster signalling
responses (Fig. 2). Second, it is fully reversible in the minute
timescale and enables precisely controlled repetitive activation
(Fig. 3a–d). Third, it allows spatially restricted activation of cell
signalling (Figs 3e and 5). Fourth, it lacks off-target effects and
has cell-type speciﬁcity (Fig. 3f). In addition, it causes induction
of transient and sustained protein activity by a single and a
repetitive illumination, respectively (Supplementary Fig. 4 and
Fig. 4a), thus providing a simple means to manipulate the
functional duration of signalling.
In summary, optoTrkB enables versatile control of TrkB
signalling and thus allows quantitative investigation of spatio-
temporal signalling dynamics in vitro and in vivo. Moreover, it
recapitulates BDNF/TrkB signalling activity in response to light,
thereby possessing beneﬁcial properties from both cell biological
and therapeutic perspectives19. Further engineering of optoTrk
receptors to a truncated form to prevent endogenous ligand
binding10 could make this tool readily applicable to in vivo
systems.
Methods
Plasmid construction. TrkB cDNA was provided by K. Kaibuchi (Nagoya
University, Nagoya), and TrkA, TrkBY816F and TrkC cDNAs were provided by L.C.
Schecterson (University of Washington, Seattle, WA). CIBN-pmGFP was provided
by C.L. Tucker (University of Colorado Denver, Denver, CO). For efﬁcient
mammalian expression, the PHR-coding sequence7 was codon-optimized (here
referred to as PHR) and listed in Supplementary Fig. 15. To construct chimeric
TrkB, we ﬁrst generated PHR-mCitrine by inserting NheI/AgeI-restricted PHR into
the corresponding sites (NheI/AgeI) of pmCitrine-C1 (Clontech) and CIBN-
mCerulean by inserting NheI/AgeI-restricted CIBN from CIBN-pmGFP into the
corresponding sites (NheI/AgeI) of pmCerulean-C1 (Clontech). Next, NheI/
BamHI-restricted TrkB, ampliﬁed by polymerase chain reaction (PCR) from TrkB
cDNA using TrkB-F (50-ggaaaagctagcATGTCGCCCTGGCCGAGGTGG-30) and
TrkB-R (50-ggaaaaggatccCCTAGGATGTCCAGGTAGACGG-30) primers was
cloned into the corresponding sites (NheI/BamHI) in the multicloning site (MCS)
of pEGFP-N1 (Clontech). The resulting TrkB-EGFP was further restricted with
NheI/BsrGI and cloned into the corresponding sites (NheI/BsrGI) of pEGFP-C1
(Clontech) to yield TrkB-EGFP-MCS. Finally, 50 blunt-ended and 30 MluI-
restricted PHR-mCitrine, PCR-ampliﬁed from the PHR-mCitrine vector using
PHR-F (50-tcgccaccATGAAGATGGACAAAAA-30) and MluI-R (50-gaaacgcgt
TTACTTGTACAGCTCGTCCATGC-30) primers, or 50 blunt-ended and 30
MluI-restricted CIBN-mCerulean, PCR-ampliﬁed from CIBN-mCerulean vector
using CIBN-F (50-tcgccaccATGAATGGAGCTATAGGAGGTGA-30) and MluI-R
primers, were inserted into TrkB-EGFP-MCS restricted with AgeI, ﬁlled in using
Klenow fragment and further restricted with MluI. The resulting constructs,
TrkB-PHR-mCitrine (optoTrkB) and TrkB-CIBN-mCerulean, encode full-length
TrkB fused to PHR-mCitrine and CIBN-mCerulean, respectively, via a linker
derived from pEGFP-N1 (DPPVAT). TrkB-CIBN-mCitrine was cloned following
the same procedures described above, and TrkB-mCitrine was constructed by
excising PHR from TrkB-PHR-mCitrine by using AgeI and re-ligating it.
TrkB-PHRD387A-mCitrine was generated by site-directed mutagenesis, as
described32, using AgeI-PHR-F (50-ggatccaccggtcgccaccATGA-30), (D387A)PHR-R
(50-CCAAGTCGGCGGCGAGAAGGGTA-30), (D387A)PHR-F (50-TACCCTTCT
CGCCGCCGACTTGG-30) and PHR-AgeI-R (50-cggcagcccaccggtCGCCA-30)
primers. TrkBY816F-PHR-mCitrine was constructed by replacing TrkB from TrkB-
PHR-mCitrine with PCR-ampliﬁed TrkBY816F using BamHI and NheI restriction
sites. TrkA-PHR-mCitrine (optoTrkA) and TrkC-PHR-mCitrine (optoTrkC) were
constructed by inserting TrkA and TrkC cDNAs in place of the TrkB of optoTrkB
using In-Fusion HD Cloning Kits (Clontech). The CMV (cytomegalovirus)
promoter of optoTrkB was replaced by PGK (phosphoglycerate kinase 1) promoter
of pPGK-Cre-bpA (plasmid 11543, Addgene) by AseI and NheI digestion.
ERK-mCherry was constructed by transferring the coding region of an Erk1 entry
clone, created using Alliance for Cellular Signaling (AfCS) vector pEX_EF1_Erk1-
YFP (AfCS barcode: A05XP002A1NK), into an mCherry expression vector using
LR Clonase (Invitrogen). mCherry-PHAKT1 has been described previously18 and
the R-GECO1 expression vector (CMV-R-GECO1) is available from Addgene
(plasmid 32444). mCherry-LifeAct was constructed by replacing GFP from
GFP-LifeAct25 to mCherry by using NheI and BsrGI restriction sites.
Reagents. Recombinant human BDNF was purchased from R&D Systems (cat.
no. 248-BD) and reconstituted in sterile phosphate-buffered saline (PBS). K252a
(cat. no. K1639) and U73122 (PLC inhibitor; cat. no. U6756) were purchased from
Sigma-Aldrich and dissolved in dimethyl sulfoxide (DMSO). LY294002 (PI3K
inhibitor) was obtained from LC Laboratories (cat. no. L-7962) and dissolved in
DMSO. PD0325901 (MEK inhibitor) was obtained from Cayman Chemical (cat.
no. 13034) and dissolved in DMSO. Poly-D-lysine hydrobromide was obtained
from Sigma-Aldrich (cat. no. P6407).
Cell culture and transfection. HeLa (American Type Culture Collection, ATCC)
cells were cultured in Dulbecco’s modiﬁed Eagle’s medium (DMEM; cat. no. E15-
843; PAA Laboratories GmbH) supplemented with 10% fetal bovine serum (FBS;
cat. no. A12617; Gibco, Invitrogen) at 37 C in a humidiﬁed 10% CO2 atmosphere.
The PC12 subline, Neuroscreen-1 (here referred to as PC12; Cellomics)33, was
provided by T. Meyer (Stanford University, Stanford, CA) and cultured in F-12K
media (cat. no. 10-025-CV; Cellgro) supplemented with 15% horse serum (cat. no.
16050-122; Gibco, Invitrogen) and 5% FBS at 37 C and 5% CO2. Cells were
transfected using a Microporator (Neon Transfection System; Invitrogen)
according to the manufacturer’s instructions. In brief, for live-cell imaging, 2 105
HeLa or PC12 cells were mixed with a total of 0.6 mg DNA (0.3mg each DNA in
cotransfection experiments), electroporated, diluted 1:5 and seeded into a 96-well
glass-bottom microplate (cat. no. MGB096-1-2-LG-L; Matrical Bioscience). For
immunoblot analysis, 5 105 HeLa or 2 106 PC12 cells, transfected by
electroporation with a total of 6 mg DNA, were seeded per well of a six-well plate.
Preparation and transfection of hippocampal neurons. E18 pregnant Sprague–
Dawley female rats were prepared for hippocampal cultures. All experimental
procedures were approved by the Animal Ethic Committee at the Korea Advanced
Institute of Science and Technology (KAIST; Daejeon, Korea). In brief, embryos
were obtained from the rats and then placed into Hank’s Balanced Salt Solution
(HBSS) (cat. no. 14185-052; Gibco)–HEPES (10mM; cat. no. 15630-080; Gibco)
solution. Hippocampi were dissected from the embryos and incubated in 0.25%
trypsin for 25min at 37 C with tapping every 5min. Hippocampi were washed for
three times with HBSS–HEPES, and triturated with a ﬁre-polished Pasteur pipette.
Tissues were dissociated after 10–20 trituration, and neurons were immediately
plated in pre-equilibrated dishes or plates coated with 1mgml 1 poly-L-lysine
(cat. no. P2636; Sigma) in plating medium. The plating medium consisted of
Neurobasal medium (cat. no. 21103-049; Gibco) supplemented with 2% FBS, 2%
B-27 (cat. no. 17504-044; Gibco), 2% glutamax (cat. no. 35050-061; Gibco) and 2%
penicillin–streptomycin (cat. no. 15140-122; Gibco). The neurons were incubated
at 37 C in a humidiﬁed 5% CO2 atmosphere. Plating medium were replaced with
maintaining medium (plating medium without FBS) within 6–24 h. Neurons were
transfected with LipofectamineLTX and plus reagent (Invitrogen) in Opti-MEM
(Invitrogen) following manufacturer’s instruction. In brief, total 0.5 mg of DNA was
incubated with 0.5 ml of plus reagent in 100ml of Opti-MEM for 5min, and then
0.5 ml LipofectamineLTX was added to the mixture. After 20min incubation at
room temperature, 20 ml from 100 ml mixture was dropped into a well of a 96-well
microplate where the medium was completely replaced to 100 ml of the new
maintaining medium. The medium was then replaced to the kept conditioned
medium after 45min.
Live-cell imaging, photostimulation and data acquisition. Cells were imaged
24 h after transfection. Before monitoring ERK and AKT activity, transfected HeLa
cells were serum-starved for 6 h. Just before imaging ERK, AKT and Ca2þ activity,
the medium was replaced with Dulbecco’s PBS containing glucose (cat. no.
14287080; Invitrogen). Neurite outgrowth was observed by imaging transfected
PC12 cells in serum-free medium (F-12K).
Live-cell imaging was performed using a Nikon A1R confocal microscope
(Nikon Instruments) mounted onto a Nikon Eclipse Ti body and equipped with
CFI Plan Apochromat VC objectives (60 /1.4-numerical aperture (NA) oil or
40 /0.95-NA air; Nikon) and a Chamlide TC system (maintained 37 C and 10 or
5% CO2; Live Cell Instrument, Inc., Korea). mCerulean, GFP, mCitrine and
mCherry images (512 512 pixels, 72.7 mm2) were taken using 457-, 488-, 514-
and 561-nm laser lines, respectively. A built-in photo activation illumination unit
was used to excite the illumination volume (generally conﬁned to a single cell
except for the experiments shown in Fig. 3f and Supplementary Movies 2 and 3)
with 488-nm light during live-cell imaging. The 488-nm laser intensity used for
photostimulation (6.5 mW per 72.7m2¼ 1.27mW cm 2; here denoted simply as
6.5 mW) was measured right above the objective. The images were analysed with
Nikon imaging software (NIS-element AR 64-bit version 3.10; Laboratory Imaging)
and MetaMorph software (version 7.6.0.0; MDS Analytical Technologies).
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Electronics. An optical power meter (cat. no. 8230E; ADCMT, Japan) was used to
measure blue-light intensity. We used two types of illumination devices consisting
of 24 and 96 blue LEDs (cat. no. PP465-8L63-ESESBI; Photron, Korea) mounted
on a customized array (Live Cell Instrument, Inc.; Supplementary Fig. 16). For the
24 LED array, each set of four LEDs was positioned at the centre of each well of a
six-well plate. The LEDs emitted an equal intensity blue light onto cells in a six-well
plate (5.5mW, measured 1 cm from the LEDs) and the light pulses were controlled
using a digital time switch (cat. no. TR 611 top2; Theben). The 96 LEDs were
positioned to ﬁt into wells of a 96-well glass-bottom microplate, and eight LEDs in
each column were simultaneously controlled using Micro-manager software
(version 1.4.15) to allow independent control of 12 columns.
Immunoblot analysis. Whole-cell lysates were prepared in the dark using PRO-
PREP solution (cat. no. 17081; iNtRON Biotechnology) and 20 mg of total protein
was resolved on a NuPAGE Novex 4–12% Bis-Tris gel (Invitrogen). Proteins were
transferred to a nitrocellulose membrane using an iBlot Transfer Stack and iBlot
Gel Transfer Device (Invitrogen) according to the manufacturer’s instructions. The
membrane was immunoblotted by incubating ﬁrst with primary rabbit anti-TrkB
(1:1,000; cat. no. 4606; Cell Signaling Technology), rabbit anti-phospho-Erk1/2
(1:1,000; cat. no. 9101; Cell Signaling Technology), rabbit anti-Erk1/2 (1:1,000; cat.
no. 9102; Cell Signaling Technology), rabbit anti-b-tubulin (1:1,000; cat. no.
04-1049; Millipore) and/or mouse anti-b-actin (1:1,000; cat. no. A5316; Sigma)
antibodies, and then with horseradish peroxidase conjugated anti-rabbit immu-
noglobulin (IgG-HRP) (1:3,000; cat. no. NA934V; GE Healthcare) or anti-mouse
IgG-HRP (1:3,000; cat. no. sc-2005; Santa Cruz Biotechnology) secondary anti-
bodies, as appropriate, using standard procedures. Proteins were visualized using
SuperSignal West Pico Chemiluminescent Substrate (cat. no. 34080; Thermo
Scientiﬁc) and a ChemiDoc MP system (Bio-Rad). For the blots shown in
Supplementary Figs 4 and 7, following secondary antibodies were used: goat-anti-
mouse IR Dye 800CW (1:3,000; cat. no. 926-32210; LI-COR) or goat-anti-rabbit IR
Dye 600CW (1:3,000; cat. no. 626-68071; LI-COR). These blots were scanned by
Odessey CLx Infrared Imaging system (LI-COR). Densitometric analysis was
carried out on the immunoblots using MetaMorph software. Uncropped gel scans
of all western blots in this paper were presented in Supplementary Fig. 17.
Neurite outgrowth assay. OptoTrkB-transfected PC12 cells in poly-D-lysine-
coated 96-well plates were serum-starved for 24 h and either left unstimulated,
treated with BDNF (50 ngml 1) or exposed to pulsatile illumination (5-s
irradiation every 5min, 470 nm, 5.5 mW) administered with a blue LED array for an
additional 24 h in serum-free media at 37 C in a humidiﬁed 5% CO2 environment.
All the samples were kept in the dark for the duration. Cells were ﬁxed by incu-
bating with a 4% methanol-free formaldehyde solution in PBS (cat. no. 28908;
Thermo Scientiﬁc) and permeabilized with 0.1% Triton X-100 in PBS. Filamentous
actin was stained with Alexa Fluor 594-conjugated phalloidin (cat. no. A12381;
Invitrogen) and cells were imaged using a confocal microscope. The number
of neurite-presenting cells, the total neurite length and the length of the
longest neurite were measured and analysed with ImageJ software (http://
rsbweb.nih.gov/ij/).
Freshly dissociated hippocampal neurons (DIV 0) were transfected with
optoTrkB and after 24 h, they were either non-stimulated or stimulated with BDNF
(100 ngml 1) or light pulses (25 mW) at 37 C in a humidiﬁed 5% CO2
environment for additional 48 h. All the samples were kept in the dark for the
duration. Cells were ﬁxed by incubating with a 4% methanol-free formaldehyde
solution in PBS and imaged using a confocal microscope. The total neurite length
and the number of branch points per cell were measured and analysed using
MetaMorph software.
Filopodia formation assay. For the live-cell imaging, neurons at DIV 5–7 were
transfected with TrkB-mCitrine or optoTrkB and mCherry-LifeAct. After 24 h,
they were treated with BDNF (100 ngml 1) or light pulses (6.5 mW) for 1 h and
images were taken using a confocal microscope. For the analysis of ﬁxed samples,
neurons at DIV 5 were transfected with TrkB-mCitrine or optoTrkB and exposed
to BDNF (100 ngml 1) or light pulses using a blue LED array (25 mW) for
30min, respectively. Cells were ﬁxed, permeabilized, stained with Alexa Fluor
594-conjugated phalloidin, and then imaged using a confocal microscope.
Filopodia were deﬁned as any protrusion under 10 mm in length. The number of
ﬁlopodia per 10mm were measured and analysed using Nikon imaging software.
References
1. Rosenbaum, D. M., Rasmussen, S. G. F. & Kobilka, B. K. The structure and
function of G-protein-coupled receptors. Nature 459, 356–363 (2009).
2. Lemmon, M. A. & Schlessinger, J. Cell signaling by receptor tyrosine kinases.
Cell 141, 1117–1134 (2010).
3. Airan, R. D., Thompson, K. R., Fenno, L. E., Bernstein, H. & Deisseroth, K.
Temporally precise in vivo control of intracellular signalling. Nature 458,
1025–1029 (2009).
4. Oh, E., Maejima, T., Liu, C., Deneris, E. & Herlitze, S. Substitution of 5-HT1A
receptor signaling by a light-activated G protein-coupled receptor. J. Biol.
Chem. 285, 30825–30836 (2010).
5. Yazawa, M., Sadaghiani, A. M., Hsueh, B. & Dolmetsch, R. E. Induction of
protein-protein interactions in live cells using light. Nat. Biotechnol. 27,
941–U105 (2009).
6. Levskaya, A., Weiner, O. D., Lim, W. A. & Voigt, C. A. Spatiotemporal control
of cell signalling using a light-switchable protein interaction. Nature 461,
997–1001 (2009).
7. Kennedy, M. J. et al. Rapid blue-light-mediated induction of protein
interactions in living cells. Nat. Methods 7, 973–U948 (2010).
8. Rutkowska, A. & Schultz, C. Protein tango: The toolbox to capture interacting
partners. Angew. Chem. Int. Ed. Engl. 51, 8166–8176 (2012).
9. Muthuswamy, S. K., Gilman, M. & Brugge, J. S. Controlled dimerization of
ErbB receptors provides evidence for differential signaling by homo- and
heterodimers. Mol. Cell. Biol. 19, 6845–6857 (1999).
10. Whitney, M. L., Otto, K. G., Blau, C. A., Reinecke, H. & Murry, C. E. Control of
myoblast proliferation with a synthetic ligand. J. Biol. Chem. 276, 41191–41196
(2001).
11. Alfa, R. W., Tuszynski, M. H. & Blesch, A. A novel inducible tyrosine kinase
receptor to regulate signal transduction and neurite outgrowth. J. Neurosci. Res.
87, 2624–2631 (2009).
12. Patapoutin, A. & Reichardt, L. F. Trk receptors: mediators of neurotrophin
action. Curr. Opin. Neurobiol. 11, 272–280 (2001).
13. Squinto, S. P. et al. TrkB encodes a functional receptor for brain-derived
neurotrophic factor and neurotrophin-3 but not nerve growth-factor. Cell 65,
885–893 (1991).
14. Watson, F. L. et al. Rapid nuclear responses to target-derived neurotrophins
require retrograde transport of ligand-receptor complex. J. Neurosci. 19,
7889–7900 (1999).
15. Zhao, Y. X. et al. An expanded palette of genetically encoded Ca2þ indicators.
Science 333, 1888–1891 (2011).
16. Liu, H. T. et al. Photoexcited CRY2 interacts with CIB1 to regulate
transcription and ﬂoral initiation in Arabidopsis. Science 322, 1535–1539
(2008).
17. Shankaran, H. et al. Rapid and sustained nuclear-cytoplasmic ERK oscillations
induced by epidermal growth factor. Mol. Syst. Biol. 5, 332 (2009).
18. Yang, H. W. et al. Cooperative activation of PI3K by Ras and Rho family small
GTPases. Mol. Cell 47, 281–290 (2012).
19. Nagahara, A. H. & Tuszynski, M. H. Potential therapeutic uses of BDNF in
neurological and psychiatric disorders. Nat. Rev. Drug Discov. 10, 209–219
(2011).
20. Marshall, C. J. Speciﬁcity of receptor tyrosine kinase signaling - transient versus
sustained extracellular signal-regulated kinase activation. Cell 80, 179–185
(1995).
21. Vaudry, D., Stork, P. J. S., Lazarovici, P. & Eiden, L. E. Signaling pathways for
PC12 cell differentiation: making the right connections. Science 296, 1648–1649
(2002).
22. Iwasaki, Y., Ishikawa, M., Okada, N. & Koizumi, S. Induction of a distinct
morphology and signal transduction in TrkB/PC12 cells by nerve growth
factor and brain-derived neurotrophic factor. J. Neurochem. 68, 927–934
(1997).
23. Schecterson, L. C. & Bothwell, M. Neurotrophin receptors: old friends with new
partners. Dev. Neurobiol. 70, 332–338 (2010).
24. Lu, B. BDNF and activity-dependent synaptic modulation. Learn. Mem. 10,
86–98 (2003).
25. Riedl, J. et al. Lifeact: a versatile marker to visualize F-actin. Nat. Methods 5,
605–607 (2008).
26. Fukata, Y., Kimura, T. & Kaibuchi, K. Axon speciﬁcation in hippocampal
neurons. Neurosci. Res. 43, 305–315 (2002).
27. Segal, R. A. Selectivity in neurotrophin signaling: theme and variations. Ann.
Rev. Neurosci. 26, 299–330 (2003).
28. Huang, E. J. & Reichardt, L. F. Trk receptors: roles in neuronal signal
transduction. Ann. Rev. Biochem. 72, 609–642 (2003).
29. Toettcher, J. E., Voigt, C. A., Weiner, O. D. & Lim, W. A. The promise of
optogenetics in cell biology: interrogating molecular circuits in space and time.
Nat. Methods 8, 35–38 (2011).
30. Hollis, E. R., Jamshidi, P., Low, K., Blesch, A. & Tuszynski, M. H. Induction of
corticospinal regeneration by lentiviral trkB-induced Erk activation. Proc. Natl
Acad. Sci. USA 106, 7215–7220 (2009).
31. Bugaj, L. J., Choksi, A. T., Mesuda, C. K., Kane, R. S. & Schaffer, D. V.
Optogenetic protein clustering and signaling activation in mammalian cells.
Nat. Methods 10, 249–252 (2013).
32. Heckman, K. L. & Pease, L. R. Gene splicing and mutagenesis by PCR-driven
overlap extension. Nat. Protoc. 2, 924–932 (2007).
33. Dijkmans, T. F. et al. Temporal and functional dynamics of the transcriptome
during nerve growth factor-induced differentiation. J. Neurochem. 105,
2388–2403 (2008).
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5057 ARTICLE
NATURE COMMUNICATIONS | 5:4057 |DOI: 10.1038/ncomms5057 | www.nature.com/naturecommunications 9
& 2014 Macmillan Publishers Limited. All rights reserved.
Acknowledgements
We thank K. Kaibuchi, L. C. Schecterson, and C. L. Tucker for sharing plasmids. In
addition, we thank Su Yeon Choi from Eunjoon Kim’s laboratory at IBS/KAIST and
Seock Kang from Myoung-Goo Kang’s laboratory at IBS for guiding us how to culture rat
primary hippocampal neurons. This work was supported by the National Research
Foundation of Korea Stem Cell Program (no. 2011-0019509), the Intelligent Synthetic
Biology Center of Global Frontier Project (no. 2011-0031955), the National Leading
Research Laboratory Program (to D.K.; 2011-0028772), the National Research
Foundation of Korea (NRF) grant funded by the Ministry of Science and Future Planning
(2010-0027941) and the Korea Advanced Institute of Science and Technology Future
Systems Healthcare Project funded by the Ministry of Science, Information and
Communication Technology & Future Planning in Korea.
Author contributions
W.D.H. and K.-Y.C. conceived the idea, and W.D.H. directed the work; K.-Y.C. and
D.W. designed experiments; K.-Y.C., D.W., H.J., S.K., J.W., T.K. and H.P. performed
experiments; S.L., N.K. and H.W.Y. supervised microscopy experiments and assisted data
analysis; J.-Y.P., E.M.H. and D.K. gave speciﬁc comments on overall experiments and
data conﬁguration; K.-Y.C., D.W., H.J. and W.D.H. wrote the paper.
Additional information
Supplementary Information accompanies this paper at http://www.nature.com/
naturecommunications
Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
How to cite this article: Chang, K.-Y. et al. Light-inducible receptor tyrosine kinases that
regulate neurotrophin signalling. Nat. Commun. 5:4057 doi: 10.1038/ncomms5057
(2014).
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5057
10 NATURE COMMUNICATIONS | 5:4057 | DOI: 10.1038/ncomms5057 | www.nature.com/naturecommunications
& 2014 Macmillan Publishers Limited. All rights reserved.
